Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328 - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328

This study is ongoing, but not recruiting participants.

Study NCT00000923 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: November 2, 1999 Last Updated: September 16, 2008 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

HIV Infections

Additional conditions recognized in this trial

Acquired Immunodeficiency Syndrome
Infection

More general conditions related to this trial

Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases

Interventions listed in this trial

Indinavir sulfate
Lamivudine
Stavudine
Zidovudine
Didanosine
Aldesleukin

Additional drug interventions recognized in this trial

Indinavir
Interleukin-2

Sponsors listed in this trial

National Institute of Allergy and Infectious Diseases (NIAID)

Back to top of Main Content